Chiron Real Estate Inc. is an internally managed real estate investment trust that acquires and manages healthcare facilities leased to physician groups and regional or national healthcare systems. The company's portfolio consists primarily of medical office buildings, inpatient rehabilitation facilities, and surgical hospitals, with additional holdings in long-term acute care, behavioral health, and emergency departments. Properties are located across the United States, with significant concentrations in Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois. The company leases most facilities to single tenants under triple-net leases, with significant tenants including LifePoint Health, Encompass Health Corporation, and Memorial Health System. Chiron Real Estate Inc. operates through its subsidiary Chiron Real Estate LP and serves as the managing member of a joint venture with Heitman. The company changed its name from Global Medical REIT Inc. in February 2026.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry REIT - Healthcare Facilities Homepage chironre.com
Sector Real Estate IR page chironre.com/investor
Tags
medical office buildings, inpatient rehabilitation, surgical hospitals, triple-net leases, healthcare real estate, physician groups, regional healthcare systems, Chiron Real Estate LP, Chiron Real Estate GP LLC, Heitman Joint Venture, LifePoint Health, Encompass Health Corporation, Memorial Health System
Press page —

Metrics

Valuation  
Market cap $ 460.455M
Market cap (USD) $ 460.455M
P/E 9.74
PEG —
P/BV 0.71
P/S 62.66
P/OCF 6.49
P/FCF —
Dividend yield 2.4%
Turnover / mcap —
Returns  
ROE -1.3%
ROI -1.3%
ROIC -1.3%
Profit margin -1,308.6%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock —
Diluting (TTM) No
Debt/Equity 0.23%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 11
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2013 FY 2012
Revenue 526K 370K 115K 116K 132K 212K 211K 54K 30.344M 8.21M 2.062M — —
Net profit -6.883M 6.692M 21.734M 19.996M 18.342M -2.499M 9.588M 14.561M -87K -6.353M -1.609M -45.338K -50.108K

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2013 FY 2012
Share price 33.74 7.72 11.1 9.48 17.75 13.06 13.23 8.89 8.2 8.92 — — —
Price performance 12m 3.37 -0.3 0.17 -0.47 0.36 -0.01 0.49 0.08 -0.08 — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Lease liabilities (USD) — — 2.67M 11M 19.4M 3.23M 2.92M 7.68M 7.46M 13.4M
Cash and deposits (USD) 19.7M 5.11M 3.63M 2.77M 5.51M 7.21M 4.02M 1.28M 6.82M 9.08M
Intangible assets (USD) 7.14M 29.3M 36.3M 59.1M 73.3M 87.7M 91.2M 65.5M 53.7M 46M
Right-of-use assets (USD) — — 2.2M 3.08M 3.6M — — 7.63M 7.27M 13.1M
Cash flow detail
Operating cash flow (USD) -2.72M 11.6M 24.8M 36.4M 34.5M 69M 76.5M 68.4M 70M 73.6M
Change in payables (cash effect) (USD) -39,509 1.36M 1.52M 857,000 1.56M 1.92M 4.06M -2.02M 2.98M 3.17M
Dividends paid (cash effect) (USD) -3.88M -745,000 -5.82M -5.82M -5.82M -5.82M -5.82M -5.82M -5.82M -5.82M
Share buybacks (cash effect) (USD) — — — — — — — — — -6M
Interest paid (cash effect) (USD) -4.1M -5.75M -13.1M -16.3M -16.9M -17.7M -21.6M -30.1M -26.6M -27.8M
Share-based compensation (USD) 1.68M 1.8M 2.67M 3.34M 5.32M 5.81M 4.68M 4.24M 5.1M 4.5M
Income detail
Total comprehensive income (USD) -6.35M -87,000 10.8M 6.64M -14M 29.9M 61.3M 12.2M 180,000 -19.4M
Comprehensive income to owners (USD) -6.35M -87,000 10.8M 6.64M -14M 29.9M — — — —
Reported Mar 11, 2019 Mar 11, 2019 Mar 9, 2020 Mar 9, 2020 Mar 8, 2021 Mar 1, 2022 Mar 1, 2023 Feb 28, 2024 Mar 2, 2026 Mar 2, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Bethesda, MD – November 4, 2026 – (BUSINESS WIRE) – Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), today announced financial results for the three months ended September 30, 2026 and other data.

Mark Decker, Jr., Chief Executive Officer and President stated, “We continue to make meaningful progress executing our strategy, including our efforts to monetize the outpatient medical portfolio. We are encouraged by the strength of the market for high-quality medical office assets and the level of investor interest we have seen. At the same time, we continue to expand our seniors housing platform and are building a growing pipeline of attractive investment opportunities that we believe can position Chiron to thoughtfully redeploy capital and drive long-term growth.”

NOTE: All share and per share data have been adjusted for all periods presented to reflect the Company’s one-for-five reverse stock split that was effective September 19, 2025.

Quarterly Financial Highlights

•Reported quarterly net loss attributable to common stockholders of $8.9 million, or $0.67 per share, as compared to net loss of $6.0 million, or $0.45 per share, in the comparable prior year period.

October 19, 2026

BETHESDA, Md.--(BUSINESS WIRE)-- Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”), announced today that it intends to release its third quarter 2026 financial results after the market closes on Wednesday, November 4, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, November 5, 2026, at 9:00 a.m. Eastern Time.

Webcast Information

Participants may access the call via live webcast by visiting the “Investor Relations” section of the Company's new website at www.chironre.com/investor/investor-overview/default.aspx . The Company encourages use of the webcast due to potential extended wait times to access the conference call via dial-in.

Conference Call

For those unable to access the webcast, participants should dial 1-800-717-1738 or 1-646-307-1865.

Replay Information

A replay of the call will be available from approximately 12:00 p.m. Eastern Time on November 5, 2026, through 11:59 p.m. Eastern Time on November 19, 2026. To access the replay, the domestic dial-in number is 1-844-512-2921, the international dial-in number is 1-412-317-6671, and the passcode is 1107155. The archive of the webcast will be available on the Company's website for a limited time.

About Chiron

Chiron is a real estate investment trust (“REIT”) focused on investing in the future of healthcare. At Chiron we strive to deliver value at the intersection of care, capital and real estate. Additional information about Chiron can be obtained on its website at www.chironre.com .

Investor Relations:
Email: [email protected]

Phone: 202.524.6869

Source: Chiron Real Estate Inc.

View All News

October 7, 2026

BETHESDA, Md.--(BUSINESS WIRE)-- Chiron Real Estate Inc. (NYSE: XRN) (the “Company” or “Chiron”) announced today that its Board of Directors has appointed Charles P. Fitzgerald as Chairman of the Board, effective immediately. Jeffrey Busch, the Company’s founder and outgoing Chairman, will remain a director following this transition.

Mr. Fitzgerald has served as a director of Chiron since May 2026 and is the Founder and Managing Partner of Maewyn Capital Partners LLC (“Maewyn”), a Dallas-based investment firm focused on unlocking value across markets and cycles through both private real estate opportunities and select public real estate investments. In May 2026, Maewyn and its investment partners made a $100 million strategic investment in Chiron through a convertible perpetual preferred security designed to provide the Company with long-duration capital to support its growth and strategic transformation.

Mr. Fitzgerald brings nearly three decades of experience investing in public real estate securities. Prior to founding Maewyn in 2025, he was the Founder, Managing Partner and Co-Portfolio Manager of V3 Capital Management. Earlier in his career, he held investment and portfolio management positions at High Rise Capital Management, J.P. Morgan Investment Management, and Prudential Real Estate Investors. His investment approach has consistently emphasized fundamental real estate analysis, disciplined capital allocation, shareholder alignment and long-term partnerships with management teams and boards. He currently serves on the board of FrontView REIT (NYSE : FVR).

“Charles has been an important partner to Chiron since joining the Board, and his perspective as both a significant investor and an experienced public real estate investor has been invaluable as we execute our strategy,” said Mark Decker Jr., President and Chief Executive Officer of Chiron. “His appointment as Chairman reflects the Board’s continued focus on shareholder alignment, disciplined capital allocation and execution. I look forward to working closely with Charles and the entire board as we continue Chiron’s transformation and build a differentiated senior housing and healthcare real estate platform.”

“I am honored to serve as Chairman at an important point in Chiron’s evolution,” said Mr. Fitzgerald. “When Maewyn and our partners invested in the Company earlier this year, we did so because we saw a compelling opportunity to transform Chiron into a higher-growth, higher-return real estate platform. Mark and the team have moved with purpose to reposition the portfolio, recycle capital, and significantly expand Chiron’s senior housing capabilities.”

“Our overriding objective is to compound long-term value for our shareholders on a per-share basis. Maewyn and our partners have significant capital invested alongside our fellow shareholders, and that alignment is central to how we approach every decision. I look forward to working with Mark, the management team and my fellow directors as we continue to build Chiron for the long term.”

In connection with this leadership transition, the Board determined that a separate Lead Independent Director position is no longer necessary.

About Chiron

Chiron is a real estate investment trust (“REIT”) focused on investing in the future of healthcare. At Chiron we strive to deliver value at the intersection of care, capital and real estate. Additional information about Chiron can be obtained on its website at www.chironre.com .

Forward-Looking Statements

Certain statements contained herein may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company’s intent that any such statements be protected by the safe harbor created thereby. These forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "plan," "predict," "project," "will," "continue" and other similar terms and phrases, including references to assumptions and forecasts of future results. Except for historical information, the statements set forth herein including, but not limited to, the timing and/or successful completion of any acquisitions or the future performance of any such acquisitions, are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although the Company believes that the expectations, estimates and assumptions reflected in its forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of the Company’s forward-looking statements. Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and in our other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and undertakes no obligation, to update any forward-looking statement.

Investor Relations
Email: [email protected]

Phone: 202-524-6869

Source: Chiron Real Estate Inc.

View All News

Prompts

Chiron Real Estate Inc. (ticker XRN), listed in United States.

Company History

Date Change Detail
Feb 25, 2026 Renamed GLOBAL MEDICAL REIT INC. → CHIRON REAL ESTATE INC.
Feb 7, 2014 Renamed SCOOP MEDIA, INC. → GLOBAL MEDICAL REIT INC.
— Former tickers GMRE

ETFs Holding Chiron Real Estate Inc.

ETF Weight in ETF Shares Market value As of
BLDG 1.24% 23,474 $ 833.327K Jul 31, 2026
RFDA 0.47% 10,521 $ 384.017K Aug 31, 2026
FESM 0.05% 69,532 $ 2.609M Jun 30, 2026
DFAR 0.02% 78,172 $ 2.078M Nov 12, 2026
IVSS 0.02% 166 $ 6,228.32 Jun 30, 2026
RESM 0.02% 22 $ 825.44 Jun 30, 2026
DFGR 0.02% 25,187 $ 669.47K Nov 12, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
XRN canonical Common share — US nyse 34.76 USD 2026-09-30
XRN$A Preferred — US nyse — —
XRN$B Preferred — US nyse — —